SFSergio Mazzola Poli de Figueiredo

Sergio Mazzola Poli de Figueiredo

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Sergio Mazzola Poli de Figueiredo has a total of 151 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • LigaSure versus conventional excisional haemorrhoidectomy: A systematic review and meta‐analysis with trial sequential analysis of randomised controlled trials

    by Gabriel Leal Barone, Bernardo Fontel Pompeu, Lucas Monteiro Delgado, Giulia Luiza Garcia, Patrícia Viana, Claudia Theis, Sergio Mazzola Poli de Figueiredo, Fernanda Bellotti Formiga

    Background: Conventional excisional haemorrhoidectomy remains the gold standard treatment for grade IV haemorrhoids, although energy‐based devices may reduce postoperative pain. We performed a systematic review and meta‐analysis of randomised controlled trials comparing LigaSure with conventional haemorrhoidectomy. Methods: A systematic search of PubMed, Scopus, Web of Science and the Cochrane Central Register was performed up to July 2025. Randomised controlled trials comparing LigaSure with conventional techniques were included. Pooled risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated using random‐effects models. Heterogeneity was assessed with the I 2 statistic, and trial sequential analysis (TSA) was applied to assess conclusiveness. Results: Forty‐three unique RCTs comprising 3,277 participants were analysed. LigaSure was associated with lower postoperative pain scores on days 1 and 2 and during the first and second postoperative weeks, reduced analgesic requirements and intraoperative blood loss, shorter operating time and time to return to daily activities, and lower risks of postoperative wound discharge, postoperative bleeding and acute urinary retention. No statistically significant differences were observed in immediate postoperative pain, pain on postoperative day 3 or week 4, recurrence, length of hospital stay, constipation, pruritus, surgical site infection, incomplete healing, anal fissure, anal stenosis, or faecal incontinence. Conclusion: LigaSure was associated with improvements in selected early perioperative outcomes, particularly postoperative pain and return to daily activities. However, uncertainty remains for several outcomes, and evidence regarding recurrence and other long‐term anorectal outcomes remains limited.

  • Open Access

    Minimally invasive versus open abdominoperineal resection and the risk of postoperative perineal hernia: a systematic review and meta-analysis

    by Beatriz Yukari Yokoyama, Victória Recidivi e Silva, Lucas Carvalho Lemos de Souza Aguiar, Hélder Santos Gonçalves, Lucas Monteiro Delgado, Claudia Theis, Sérgio Mazzola Poli de Figueiredo, Fernanda Bellotti Formiga, Bernardo Fontel Pompeu

    Background: The impact of minimally invasive surgery on the risk of postoperative perineal hernia after abdominoperineal resection (APR) or extralevator abdominoperineal excision (ELAPE) remains uncertain. This study compares perineal hernia rates and perioperative outcomes between minimally invasive and open approaches. Methods: PubMed, Scopus, Web of Science, and Cochrane Library were searched through June 2026. Pooled odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs) were calculated using random-effects models. A Bayesian meta-analysis was additionally performed for the primary outcome. Results: Four comparative observational studies involving 763 patients were included; 249 underwent minimally invasive APR/ELAPE, and 514 underwent open APR/ELAPE. Postoperative perineal hernia was significantly more frequent following minimally invasive surgery (OR 4.13; 95% CI 2.24–7.61; p < 0.001). Intraoperative blood loss was significantly lower in the minimally invasive group (MD − 156.5 mL; 95% CI − 298.4 to − 14.5; p = 0.03), as was operative time (MD − 41.7 min; 95% CI − 60.8 to − 22.5; p < 0.01). No significant differences were observed in hospital stay (MD − 2.5 days; 95% CI − 5.4 to 0.4; p = 0.09) or 30-day readmission rates (OR 1.41; 95% CI 0.82–2.42; p = 0.209). Bayesian analysis yielded a posterior mean OR of 4.04 (95% CrI 1.96–8.36), corresponding to a 99.9% posterior probability that minimally invasive surgery increases the risk of postoperative perineal hernia. Conclusion: Minimally invasive APR/ELAPE was associated with an increased risk of postoperative perineal hernia compared with the open approach. Strategies to reduce this complication while preserving the benefits of minimally invasive surgery warrant further investigation.

  • Salvage abdominoperineal resection for anal squamous cell carcinoma: A systematic review and meta‐analysis of proportions

    by Gabriel Ribeiro Belfort, Bernardo Fontel Pompeu, Marília Piassi Velucci, Camila Haddad Baptista, Lucas Monteiro Delgado, Fábio Israel Lima Castelo Branco Marques, Claudia Theis, Leonardo de Mello Del Grande, Sérgio Mazzola Poli de Figueiredo, Fernanda Bellotti Formiga

    Aim: Salvage abdominoperineal resection (APR) remains the standard treatment for patients with persistent or recurrent anal squamous cell carcinoma after chemoradiotherapy (CRT). This study aimed to evaluate the perioperative and oncological outcomes of salvage abdominoperineal resection. Methods: A systematic review of observational studies including adult patients with persistent or recurrent anal squamous cell carcinoma undergoing salvage APR after failure of CRT was conducted using PubMed, Scopus and Cochrane through March 2026. Binary outcomes were pooled as proportions on the logit scale under random‐effects models; a generalized linear mixed model was applied when zero‐event studies were present. Continuous outcomes as means with 95% confidence intervals (CIs). Heterogeneity was assessed using the I 2 statistic. Sensitivity analyses were performed using leave‐one‐out methods. All analyses were conducted in R version 4.4.2. Results: Eighteen observational studies comprising 1,013 patients were included. The pooled 2‐year and 5‐year overall survival (OS) rates were 68.34% (95% CI: 60.42–75.33; I 2 = 65%) and 46.43% (95% CI: 38.03–55.04; I 2 = 81%), respectively. The pooled 3‐year and 5‐year disease‐free survival rates (DFS) were 50.36% (95% CI: 20.62–79.85; I 2 = 95%) and 41.79% (95% CI: 27.80–57.24; I 2 = 90%), respectively. The pooled overall recurrence rate was 44.28% (95% CI: 36.63–52.21; I 2 = 79%), including locoregional recurrence of 34.03% (95% CI: 27.22–41.57; I 2 = 72%) and distant recurrence of 17.39% (95% CI: 12.24–24.13; I 2 = 83%). The pooled R0 and R1 resection rates were 79.71% and 17.08%, respectively. Overall morbidity and major complications (Clavien–Dindo ≥III) were 50.70% and 27.97%, respectively. Thirty‐day mortality was 1.18% (95% CI: 0.36–3.85; I 2 = 0%). Sensitivity analyses showed stable estimates despite heterogeneity. Conclusion: Salvage APR for anal squamous cell carcinoma demonstrated moderate long‐term survival, acceptable R0 resection rates and substantial postoperative morbidity. However, the available evidence remains limited by high heterogeneity, non‐standardized outcome definitions and the absence of comparative data.

  • Oncologic Outcomes After Liver Transplantation for Unresectable Colorectal Liver Metastases: A Systematic Review and Meta‐Analysis of Proportions

    by Bernardo Fontel Pompeu, Lorrany Ramos Aguiar, Giuliana Daneluci Melillo, Laryssa Santana Nakabayashi, Gabriel Leal Barone, Lucas Monteiro Delgado, Claudia Theis, Leonardo de Melo Del Grande, Sérgio Mazzola Poli de Figueiredo, Fernanda Bellotti Formiga, et al.

    Liver transplantation has emerged as a therapeutic option for highly selected patients with unresectable colorectal liver metastases (CRLM). This review evaluated oncologic and perioperative outcomes in 92 patients who underwent transplantation. One‐ and 3‐year overall survival (OS) were 96.32% and 73.07%, respectively. Disease‐free survival (DFS) was lower, with high rates of recurrence. Major complications occurred in 39.36%, and 90‐day mortality was 1.03%. Further randomized studies are needed to better define the role of liver transplantation and optimize patient selection criteria


  • Open Access

    Preperitoneal extended totally extraperitoneal (PeTEP) repair for ventral hernia: A systematic review and meta-analysis

    by Ana Luíza Rocha Soares Menegat, Brenda Luana Rocha Soares Menegat, Rafaela Duarte Vergna, Bernardo Wagner, Josélio Rodrigues de Oliveira Filho, Sergio Mazzola Poli de Figueiredo, Victor Kenzo Ivano

    Purpose: Ventral hernias are common abdominal wall defects associated with substantial healthcare burden and impaired quality of life. Minimally invasive extraperitoneal techniques have evolved to optimize midline reconstruction while avoiding intraperitoneal mesh placement, especially in the setting of diastasis recti. Preperitoneal Extended Totally Extraperitoneal (PeTEP) repair is a recently introduced approach, but evidence regarding its safety and effectiveness remains limited. Therefore, we performed a systematic review and meta-analysis to synthesize the available evidence. Methods: A systematic search of PubMed, Embase, and the Cochrane Library was conducted to identify studies evaluating PeTEP repair for ventral hernia with or without rectus diastasis. Meta-analytical pooling of outcomes was performed using a random-effects model. All statistical analyses were conducted using R software (version 4.4.1). Results: Four studies were included, comprising 99 patients, with a mean age of 51.53 years and a mean body mass index of 29.55 kg/m 2 . The pooled mean operative time was 129.48 min (95% CI 74.96 to 184.00). Hematoma occurred in 10.61% of patients (95% CI 5.14 to 20.62), and overall postoperative complications in 21.21% (95% CI 12.98 to 32.69), with no intervention required in either case. Bulging was observed in 4.88% of cases (95% CI 1.22 to 17.52). No recurrences were reported across studies, with follow-up ranging from 1 to 12 months. Conclusion: Current evidence suggests that PeTEP may be a feasible minimally invasive extraperitoneal approach for ventral hernia repair. However, further comparative studies with longer follow-up are needed.

  • Endoscopic Sleeve Gastroplasty versus Laparoscopic Sleeve Gastrectomy: A Systematic Review and Meta-Analysis

    by Gabriel Barone, Larissa Mercadante de Assis, Lucas Monteiro Delgado, Patrícia Viana, Giovanna Pilon, Giulia Garcia, Lucas Soares de Souza Pinto Guedes Guedes, Fábio Israel Lima Castelo Branco Marques, Leonardo Del Grande, Cláudia Theis, et al.


  • Effect of mesh plane on short-term surgical and functional outcomes in ventral hernia repair with associated rectus diastasis

    by Claudia Theis, Victor Andrade Nunes, Marisa Blackman, Bernardo Fontel Pompeu, Sergio Mazzola Poli de Figueiredo


  • Metabolic Bariatric Surgery versus GLP-1 Receptor Agonists for Obesity Management: A Systematic Review and Meta-Analysis

    by Lucas Monteiro Delgado, Gabriel Barone, Giulia Garcia, Giovanna Pilon, Patrícia Viana, Fabio Israel Lima Castelo Branc Marques, Cristina Bellotti Formiga Bueno, Leonardo Del Grande, Cláudia Theis, Sérgio Poli de Figueiredo, et al.

    Introduction Metabolic and bariatric surgery (MBS) and glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are both effective strategies for obesity management, but their comparative efficacy remains uncertain. This systematic review and meta-analysis aimed to compare weight loss outcomes between MBS and GLP-1 RA therapy in adults with obesity. Methods A systematic search of PubMed, Scopus, and Cochrane Library was conducted from inception to September 22, 2025. Eligible studies included randomized and observational comparisons between MBS—specifically sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB)—and GLP-1 RA therapy in adults with obesity. Pooled mean differences (MDs) for total weight loss (TWL) and body mass index (BMI) change were calculated using a DerSimonian–Laird random-effects model. Risk of bias was assessed using ROBINS-I V2, and certainty of evidence was graded with GRADE. Results Five retrospective observational studies (n = 5,944; 3,489 MBS, 2,455 GLP-1 RA) met the inclusion criteria. Pooled analysis showed significantly greater TWL in the MBS group (MD − 18.15%; 95% CI 16.41 to 19.90; p < 0.0001; I² = 95%) and larger BMI reduction (MD 8.73 kg/m²; 95% CI 5.87 to 11.58; p = 0.0001; I² = 94.6%). Sensitivity analyses confirmed the robustness of these results. Overall risk of bias was moderate, primarily due to non-randomized designs and treatment selection bias. Certainty of evidence was rated as moderate. Conclusions MBS achieves significantly greater and more durable weight loss compared with GLP-1 RA therapy, reaffirming its role as the most effective intervention for severe obesity. While GLP-1 RAs represent valuable noninvasive or adjunctive options, surgery remains the benchmark for sustained metabolic and weight outcomes.


  • Is mesh fixation necessary in open retromuscular ventral hernia repair? A meta-analysis

    by Claudia Theis, Neophytos Christodoulou, Victor Andrade Nunes, Augusto Graziani e Sousa, Sergio Mazzola Poli de Figueiredo

    Purpose Retromuscular ventral hernia repair (RVHR) is a well-established and increasingly popular technique for mesh placement, offering favorable recurrence and complication rates. However, the role of mesh fixation in RVHR remains unclear, as some have questioned its effect on reducing recurrence and could potentially increase postoperative morbidity. We performed a systematic review and meta-analysis to compare outcomes of RVHR with and without mesh fixation. Methodology PubMed, EMBASE, and Cochrane Library were searched through July 2025. Eligible studies included adult patients undergoing open RVHR with or without fixation. Primary outcomes were hernia recurrence and postoperative pain; secondary outcomes included hematoma, seroma, surgical site infection (SSI), reoperation, operative time, length of stay (LOS), and quality of life. Risk of bias was assessed using RoB 2 and ROBINS-I. Random-effects models were used, and heterogeneity was quantified using the I2 statistic. Results Six studies (15,106 patients; 3,994 without fixation) met inclusion criteria: two randomized controlled trials and four observational cohorts, including one registry study. Recurrence did not differ between fixation and non-fixation (OR 1.1, 95% CI 0.91–1.34; I2 = 0%). Fixation was associated with significantly worse quality-of-life scores (MD –12.71, 95% CI –16.48 to –8.93; p < 0.001; I2 = 0%) and higher hematoma risk (OR 5.18, 95% CI 1.18–22.68; p = 0.03; I2 = 0%). No significant differences were found for pain, SSI, seroma, reoperation, LOS, or operative time. Conclusion Our systematic review and meta-analysis identified no difference in recurrence, pain, SSI, or long-term outcomes between mesh fixation and non-fixation in RVHR. However, fixation was associated with significantly worse quality-of-life scores and a higher risk of hematoma. These findings suggest a selective rather than routine use of mesh fixation in RVHR.


  • Laparoscopic totally extraperitoneal (TEP) versus laparoscopic transabdominal preperitoneal (TAPP) for bilateral inguinal hernia repair: a systematic review and meta-analysis

    by Alexandre Oliveira Carneiro, W. Rodrigo Calmet Rocca, Leonardo Braga Gonçalves, Sergio Mazzola Poli de Figueiredo